Japanese pharmaceutical company Takeda Pharmaceutical sells its Japanese consumer products business to investor Blackstone. The deal involves 242 billion yen, converted into 2.3 billion dollars. These include household brands such as Alinamin energy drinks and Benza Block medicines for colds. Takeda’s activities have lost market share to rivals in Japan in recent years. Under the wings of the new owner, an innovation lag could be set in motion to win back ground. Blackstone strives to invest heavily in the company in order to be able to bring it to the market independently in about five years. According to analysts, the part is being disposed of for less money than they would have expected. This is probably due to the coronacrisis. But Takeda could use the money. In early 2019, the Japanese completed their mega-takeover of the Irish-American Shire. That involved tens of billions of dollars. Takeda then set himself the goal of selling $ 10 billion worth of assets.
